MENA's Biological Performance OS · Seed Round 2026
Your Biological
Advantage.
Stop Guessing · Start Knowing
Founders
Mustafa Maghraby · Mariam Hourani
Stage
Seed · SAFE
Raising
USD 1M
Geography
UAE → GCC
01 / 31
Elevator Pitch
From the founders behind a UAE strategic exit (DUBZ → Emirates Group) and RawKure, a UAE-born premium functional-nutrition brand — Neotrium is MENA's first Biological Performance OS, turning DNA, blood & wearables into daily DNA-matched meals, plus a proprietary AI platform licensed to GCC clinics from Year 3.
The execution layer the GCC's $15B precision-health market is missing
Vision
02 / 31
The Peak Performance Paradox
Health is integrated.
Healthcare is segregated.
More than 500,000 HNW individuals in the UAE/GCC alone are spending USD 500–2,000 a month on health solutions — and getting fragmented PDFs in return.
01
Scattered Data
DNA test in one PDF. Blood panel in another. Wearable data in a third app. Microbiome in a fourth. No clinic owns the whole picture.
02
Friction in Execution
Translating biology into a daily action plan requires multiple specialists, multiple consultations, no single source of truth — and zero accountability.
03
No Outcome
People invest in their health and see no measurable change. Not because the science is broken — because nobody executes it daily.
UAE/GCC Health & Wellness · Alpen Capital, 2024 · WHO 2024 · Knight Frank Wealth Report 2024
$15B+ TAM written across the GCC
Problem
03 / 31
Why Neotrium Was Built
Built by founders who lived the problem.
Cancer runs through my family. My older brother was diagnosed younger than I am today. So I ran every test money could buy in the GCC — and still couldn't answer one question:
"What should I eat tomorrow morning?"
Five PDFs. Five apps. Five specialists who couldn't see each other's work. I had more biological data about myself than 99% of people on the planet — and zero way to act on it.
Neotrium is the platform that didn't exist when I needed it. No one tells you why. We tell you how to fix it.
DNA Sequencing500+ insights
Blood Biomarkers70+ markers
Wearable TelemetryContinuous
Microbiome AnalysisFull panel
Specialist Reports5 silos
"Every human is biologically unique. Peak performance — and disease prevention — requires a protocol built for that biology, updated continuously, and actually executed. Not a PDF. An operating system."
Co-founder · Mariam
Mariam Hourani — Co-Founder & Precision Nutrition Architect. Founder of RawKure, a UAE-born premium functional-nutrition brand. Stanford-certified in Nutrition Science. Autoimmune disease runs through her family — the lived experience that drove her into precision nutrition as the daily intervention. Same execution gap, food side: clients arriving with stacks of test results no one had translated into a daily plan. Together: the system Neotrium had to become.
Why Now
04 / 31
Why Now · The Window
Three tailwinds that didn't exist 24 months ago.
Neotrium is possible in 2026 because of specific, dateable changes in regulation, capital flows, and technology cost curves. This round funds the window — not an idea.
01 · Regulatory
UAE Vision 2031 & Dubai Health Strategy
Preventative and precision health elevated to national strategy. Emirati Genome Program, Dubai Longevity Strategy, and M42's healthcare consolidation have actively opened capital and regulatory runways for platforms like Neotrium.
→ AED billions reallocated to preventative health
02 · Capital
Saudi Vision 2030 & PIF Health Allocation
NEOM Health, PIF healthcare fund, and Saudi's chronic disease crisis (highest per-capita diabetes globally) create a structural buyer for precision health services at the top of the wealth pyramid — our target SAM.
→ $40B+ healthcare transformation mandate
03 · Infrastructure
Sequencing + Wearables + LLMs Inflected
DNA sequencing fell from ~$1,000 to ~$100 per test. CGM and HRV wearables are consumer-grade. LLM inference costs collapsed ~90% in 18 months. The NEO-OS economics only work at today's prices — not 2022's.
→ Unit economics viable in 2026, not before
The first platform to combine capital access, regulatory green-light, and cost-curve viability in the GCC precision-health stack wins the category. That window is open now.
Why Now · Window
05 / 31
The 360° Solution
Not a clinic. Not a meal-prep service.
A Performance System.
We transform scattered biological data into a single, expert-verified protocol — and then we execute it daily through DNA-matched meals delivered to your door.
→
Three data layers, one system.DNA + 70 blood biomarkers + continuous wearable data — fused in NEO-OS.
→
Specialist-verified protocols.Every plan reviewed by licensed nutrigenomic, fitness & therapy specialists before deployment.
→
DNA-matched meals — prepared & delivered daily.No shopping. No cooking. No food logging. We control the food, so we know what you ate.
→
Adapts in real time.If HRV drops, glucose spikes, or sleep collapses — the next day's protocol changes automatically.
Solution
06 / 31
Product · Three Engines, One System
Three engines. Zero friction.
One compounding moat.
Engine 01 · Co-Pilot
NEO-OS Co-Pilot
Checks DNA + blood + wearables before every recommendation. A specialist in your pocket — 24/7.
User: "Can I have pasta?"
NEO: "No — your MTHFR gene + low HRV today don't permit it. Try grilled salmon instead."
Engine 02 · Execution
The Execution Engine
DNA-matched meals prepared and delivered to your door daily. Because we control the food, the client never logs a meal — we already know what they ate.
This is the data moat no app-only competitor can replicate.
No shopping. No cooking. No guessing. No logging.
No shopping. No cooking. No guessing. No logging.
Engine 03 · Learning
The Learning Engine
Every specialist review trains the AI with a new rule. Every meal delivered = one new data point. Every client makes the next client's protocol smarter.
By Year 3 → the most valuable specialist-verified genomic-nutrition dataset in the GCC. The asset we license to clinics.
Product
07 / 31
The Customer Journey
From data to outcome — in 90 days.
The longer a client stays, the smarter the system gets. That is the moat.
Step 01
Day 0–2
Concierge Data Collection
A licensed professional visits at home. DNA kit + 70 blood biomarkers collected in one visit. No clinic. No waiting room. Everything flows into NEO-OS.
Step 02
Day 4
Metabolic Kickstart
Within 4 days — before DNA results arrive — the first blood-calibrated meal plan is prepared and delivered. We prepared it, so we know they ate it.
Step 03
Week 3
Genetic Deep Dive
DNA results integrated. Protocol now reflects all three layers: who you are, how your body responds, what you need today. Specialist verifies. AI learns.
Step 04
Day 90+
Continuous Optimization
Complimentary 90-day blood re-test. Wearables → adapt. New blood → update. Specialist insight → AI rule. Every month makes the system stronger.
Journey
08 / 31
The Core Differentiator
Dynamic > Static.
Every competitor gives you advice based on who you were born as. We give you advice based on who you are today.
IF
You slept < 4h last night → NEO overrides your DNA plan and prioritizes cortisol recovery (anti-inflammatory, slow-carb breakfast)
IF
HRV dropped 30% this week → system reduces training load + raises anti-inflammatory food load
IF
Blood glucose spiked yesterday → system flags the meal that caused it and removes it from tomorrow's plan
IF
DAO gene variant + new rash → histamine foods are stripped permanently, swapped with low-histamine equivalents
This is not an app. This is a closed-loop biological operating system.
Differentiator
09 / 31
Competitive Landscape
Nobody owns the data + execution + learning loop.
↑ Dynamic
Static ↓
← Data Only
Execution →
Oura · Whoop · InsideTracker
Passive monitoring. Lots of dashboards, no daily protocol, no execution.
Neotrium
DNA + Blood + Wearables → daily DNA-matched meals + adaptive AI co-pilot. The only player in this quadrant in MENA.
MyFitnessPal · Fad Diets
Generic rules. Manual logging. No biology in the loop.
Kcal · Healthy & Co
Premium meals delivered — but no DNA, no blood, no biological adaptation.
Competition
10 / 31
The Moat · Proprietary IP
NEO-OS · the proprietary knowledge engine.
Four layers. Built with this round. Licensable from Year 3.
Layer 01 · The Brain
Knowledge Base
Specialists encode a proprietary "if-then" rule database tying genetic variants to nutritional, training and supplementation responses. This is our core IP.
IF MTHFR THEN REQUIRE methyl-folate; AVOID synthetic folic acid
Layer 02 · The Decision-Maker
Prioritization Engine
Resolves conflicts between static (DNA) & dynamic (sleep, HRV, glucose) signals. The rule that runs the system: Dynamic > Static.
IF Warrior gene + High-Stress Day → Deploy Adrenal Recovery Protocol
Layer 03 · The Learning Loop
Human-in-the-Loop
AI generates protocol → specialist edits ("swap salmon for chicken — histamine sensitivity") → rule logged permanently. Every modification compounds.
IF DAO variant THEN remove histamine across ALL future protocols
Layer 04 · Kitchen Link
Protocol Generator
Recipes pre-tagged across 40+ biological parameters. Maghraby's product engine + Hourani's RawKure infrastructure means we execute from Day 1 — competitors need 12+ months & millions to replicate.
TAGS: anti-inflammatory · MTHFR-safe · DAO-compatible · low-cortisol · high-HRV
Moat
11 / 31
The Compounding Moat
The NEO Cycle: closing the loop between biology & behavior.
Every cycle adds biological data, specialist rules & outcome evidence. The cycle never stops.
→ Reveal
The Complete Picture
500+ DNA insights · 70+ blood biomarkers · wearable sync from Day 1. One platform. Zero fragmented PDFs.
→ Align
Three-Layer Triangulation
"Performance gene detected — but HRV 42 + cortisol high. Your DNA says athlete. Your body says recover." Protocol adjusts; AI logs the rule.
→ Apply
DNA-Matched Daily Meals
Prepared and delivered. Client never logs food. Supplements curated. Lifestyle protocols in-app. Zero friction.
→ Measure
Complimentary 90-Day Re-Test
We don't ask "do you feel better?" We show the biomarkers. Inflammation down. Energy up. Documented. Verifiable. Repeatable.
The only health platform in MENA that owns DATA + EXECUTION + LEARNING
Every month a client stays = stronger knowledge base
Moat Loop
12 / 31
Market Sizing
A ready, eager & under-served market.
TAM · Total Addressable~AED 20B
UAE health & wellness — fastest-growing in the world. Driven by UAE Vision 2031, Saudi Vision 2030, world-leading HNWI density & rising chronic disease.
SAM · Serviceable1.2M+ HNWI
UAE + KSA HNW professionals already spending USD 500–2,000/mo on fragmented health solutions. Outcome-sensitive, not price-sensitive.
SOM · Year 5 Target2,022 clients
Conservative bottom-up: 545 unique clients by Y2, scaling to 2,022 by Y5 across Dubai, Abu Dhabi, then KSA. 21 already paying with zero paid marketing.
TAM · UAE Wellness
AED 20B
SAM · GCC HNWI
1.2M+
SOM · Year 5
2,022 clients
Sources · Alpen Capital GCC Health & Wellness 2024 · WHO Regional 2024 · Knight Frank Wealth 2024
Vision 2031 / Vision 2030 longevity mandates
Market
13 / 31
Business Model · NEO Foundation Tiers
Three tiers · one-time fee + recurring meal plan.
Most Popular · 65%
Nourish
One-time fee
AED6,999
- 1st month meal plan included · DNA-calibrated delivery
- Master Biological Blueprint — sleep, habits, performance
- Comprehensive Elite DNA Kit · 500+ insights
- Wearable sync · NEO Starter Kit + Smart Scale
- Full NEO-OS access · 1 year exclusivity
Energize
One-time fee
AED9,999
or AED 2,500 × 4 months
- Everything in Nourish, plus:
- Concierge at-home DNA + 65 blood biomarkers
- 2 × 45-min sessions · Nutrigenomic Specialist
- 2 × 45-min sessions · Fitness Trainer Specialist
Optimize
One-time fee
AED29,999
- Everything in Energize, plus:
- Full biological analysis · microbiome + epigenetics
- 5 sessions · "Your Performance Team"
- 3 sessions · longevity therapy via partner clinics
- NEO Priority Concierge · dedicated channel
Recurring · Meal Plan AED 3,999/mo · Platform renewal annually
50% one-time → meal plan conversion (vs 47.6% live)
Pricing
14 / 31
Unit Economics
Healthy gross margin per tier.
Loss-aversion lock-in by Month 4.
Nourish
45%
Revenue / clientAED 6,999
COGS / clientAED 3,850
Profit / clientAED 4,199
Energize
40%
Revenue / clientAED 9,999
COGS / clientAED 5,950
Profit / clientAED 4,049
Optimize
43%
Revenue / clientAED 29,999
COGS / clientAED 17,120
Profit / clientAED 12,879
Year 3 · B2B Licensing
"Neotrium OS" white-label to GCC clinics: 85% gross margin, zero incremental food COGS. Setup AED 99,999 + AED 50K/mo recurring per clinic.
85%
SaaS GM
50
Clinics by Y5
If a client cancels they lose: daily meals · ongoing protocol · specialist relationship · 90-day blood re-test · 2 years of biological data history.
→ Loss-aversion retention
Economics
15 / 31
Live Traction · Validated Pre-App
We didn't build a deck. We built a business.
Paying Clients
21
Soft launch. Founder network. Zero paid marketing. Manual process.
Monthly Recurring
AED /32K
From zero in 8 weeks. 8 active meal-plan subscribers at AED 3,999/mo.
One-time → Meal Plan
50%
Updated assumption (47.6% on live cohort). Validated & baked into FM.
Platform Built
80%
NEO-OS Knowledge Base + Dashboard architecture in place. Final 20% = this round.
✓
Licensed PartnersDHA / DOH-certified labs · Practitioners onboarded & active.
✓
Kitchen InfrastructureRawKure operating since 2019 · AED ~99K Q1 2026 revenue · rolls in Day 0 (next slide).
!
App in TestingManual ops today. Round funds the final 20% to remove the bottleneck.
Traction
16 / 31
The RawKure Foundation · Brand 2019 · Meal Plans Jan 2026
A 6-year brand just validated a new product line in 90 days.
RawKure has operated a licensed premium food brand in Dubai since 2019 (desserts line). In January 2026, Mariam launched the meal-plan product — the same category Neotrium executes. Three months of data: clean product-market fit, zero paid marketing.
Since 2019 · 6 Years
Brand, Licensing & Infrastructure
→ Licensed commercial kitchen in Dubai
→ Premium food brand equity (dessert line)
→ Supplier & ingredient sourcing relationships
→ Specialist & consultant network
→ Regulatory & compliance already cleared
Competitors need 12–18 months and millions to assemble this. We start Day 0 with it.
Since Jan 2026 · 90 Days
New Meal-Plan Product Line
461
Orders · Q1 2026
AED 99K
Revenue · Q1 2026
24
Unique Shopify customers
2
Active channels
Zero paid marketing · organic only · validates the exact meal-plan execution layer Neotrium needs.
Meal Planet · Q1 2026 · Monthly Actuals
Source: Meal Planet merchant statements
Jan 2026 · launched
128 orders · AED 17,867
Feb 2026 · +30%
167 orders · AED 22,806
Mar 2026 · steady
135 orders · AED 17,053
Brand equity: 6 years. Meal-plan PMF: 90 days. Neotrium adds the biological layer.
→ Infrastructure owned · PMF proven · NEO-OS is the multiplier
RawKure Foundation
17 / 31
Partnership Pipeline · Validated Demand
We're not selling to the market — the market is calling.
Four longevity-adjacent UAE clinics and partners converged on Neotrium independently in the last 30 days. This is a demand signal that reprices the risk profile of this round.
Signed / Finalizing
Valeo
Signed · Last Week
MENA's largest funded longevity platform. Referral + clinical partnership locked in.
VEO Fitness × Emaar Hospitality
Finalizing · 4 Dubai Locations
White-label meal execution across four premium Emaar fitness properties.
Clinical Advisory Board
5 Specialists · Signed
Nutrigenomics, functional medicine, sports performance — protocol review layer.
Meal Planet
Live · Operating Partner
Active aggregator distribution — 430 orders in Q1 2026 alone.
Inbound / In Diligence
M42
Mutual NDA
Mubadala + G42 healthcare JV. Strategic conversation active.
Omics Longevity
Inbound
Unprompted partnership inquiry · longevity diagnostics platform.
Everwell
Inbound · Yesterday
Dr. Schmitz · regenerative medicine clinic. Partnership request received.
Almond Blossom Fertility
Referring Patients
Active patient referral flow to Neotrium protocols.
4 longevity-adjacent UAE clinics converged on Neotrium independently in the last 30 days. That's a demand signal, not a sales result.
Partnership Pipeline
18 / 31
Channel Mix · Bottom-Up Projection
Four active channels. 540+ active / 900+ ever-served by Month 24.
FM v1 projects 545 unique clients by FY2 via direct-to-consumer only. Layering in signed B2B channels adds an incremental 260–330 customers that are not in the current FM — representing material upside to the current projection.
Channel Breakdown · Month 24
| Channel | Type | Active M24 | Cumulative |
|---|---|---|---|
| Neotrium Direct · Recurring | DTC | ~180 | 280–320 |
| Neotrium Direct · Tier Programs | DTC | ~100 | |
| VEO Fitness · 4 Emaar locations | B2B · NS | 120–150 | 300–400 |
| Meal Planet · B2B aggregator | B2B · NS | 60–80 | 150–200 |
| Valeo + Clinic Referrals | B2B · NS | 80–100 | 150–200 |
| TOTAL · Month 24 | 540–610 | 900–1,100 | |
Active Mix · M24
+ Year 3 · B2B SaaS Overlay
10 clinics × AED 50K/mo
= AED 6M ARR,
= AED 6M ARR,
scaling to 50 clinics by FY5. 85% SaaS gross margin, zero incremental food COGS.
Channels · B2B upside not in FM
19 / 31
B2B SaaS · GCC Clinic Licensing
The $9.5M FY5 line — built bottom-up, not top-down.
The SaaS layer isn't a spreadsheet assumption. 200+ precision-health, longevity, and functional-medicine clinics operate across UAE and KSA today. Five of our first ten are already named.
TAM · Addressable Clinics
~180
UAE clinics
~90
KSA clinics
~40
Qatar + Bahrain
Precision health · functional med · longevity · fertility · regenerative · nutrigenomic clinics. Growing ~15% YoY driven by Vision mandates.
Your First 10 · 50% Named
✓ ValeoSIGNED
◐ M42MUTUAL NDA
◐ Omics LongevityINBOUND
◐ Everwell · Dr. SchmitzINBOUND
◐ Almond BlossomREFERRING
→ 5 of 10 identified · 5 remaining from 310-clinic TAM
Tiered Pricing · Per Clinic
| Tier | Setup | Mo · Rec. | Target |
|---|---|---|---|
| Starter · Single-practitioner | AED 50K | AED 25K | 30% |
| Pro · Mid-size clinic | AED 100K | AED 50K | 56% |
| Enterprise · Hospital groups | AED 200K+ | AED 100K+ | 15% |
Blended ACV target ~AED 700K · FM assumes Pro-tier economics.
Unit Economics · Pro Tier
AED 30K
CAC · Founder-led sales
<2 mo
Payback period
85%
Gross margin
AED 1.5M
3-yr LTV per clinic
Clinic SaaS · Bottom-Up
20 / 31
B2B SaaS · Live Product
The Specialist Console — what clinics actually license.
One live patient dashboard that replaces five fragmented PDFs — the actual product clinics license at AED 50–100K/month.
→ Critical Actions Queue
AI-flagged patient priorities, ranked by urgency. Lab results pending review, low compliance alerts, energy check-ins.
→ Health Snapshot
NEO Score · sleep · HRV · resting HR · activity · DNA-matched foods optimized for the patient.
→ Wellness & Compliance
Real-time meal plan / lifestyle / supplement adherence — replacing the static client check-in.
→ Biological Age Clocks
Blood · microbiome · epigenetic age — quantified outcomes the clinic can charge premium for.
Every protocol modification by the specialist trains NEO-OS — the practitioner can't switch vendors without losing 2 years of patient data.
Specialist Console
21 / 31
Go-to-Market Strategy
Education → Awareness → Engagement.
Phase 1 is already working.
Phase 01 · Pre-Launch · Complete ✓
Education
- Founder PR secured · top-tier UAE business media
- High-profile brand ambassador signed
- Targeted content driving organic waitlist
- Result: 21 clients · 50% conversion · zero paid marketing
Phase 02 · Launch · Q1 post-funding
Awareness
- Activate micro-influencer campaigns (UAE health, fitness, longevity)
- Strategic partnerships · elite gyms (Symmetry, Crank, F45) + 5★ hotels
- Convert waitlist into paying subscribers
- Wearable bundles · OURA, Whoop, Apple Watch co-marketing
Phase 03 · Post-Launch · Year 2
Engagement
- Amplify authentic UGC + before/after biomarker stories
- Video testimonials · documented blood & DNA outcomes
- Launch "NEO Cast" podcast · build the community flywheel
- B2B clinic outreach begins · prepares Year 3 SaaS launch
GTM
22 / 31
Strategic Architecture
B2C funds the AI. AI becomes the B2B product. B2B scales without COGS.
01 B2C Concierge · Profit Engine
Premium service for UAE elite. One-time tier + recurring meal plan + annual platform renewal. Funds the AI training.
02 Specialists become B2B customers
Clinics replace static PDFs with live biological dashboards. Real-time client adherence. Every practitioner edit = one new AI rule. Practitioners can't leave without losing 2 years of client data.
03 B2B SaaS · Scale Engine
"Neotrium OS" white-label · AED 50K/mo per clinic + AED 100K setup. 85% gross margin · zero food COGS · GCC clinic network = distribution.
04 Logistics-as-a-Service · Lock-in
SaaS clients fulfill via our kitchen. Volume reduces unit COGS · creates execution lock-in for SaaS subscribers.
Flywheel
23 / 31
Updated 5-Year Model · vVC · 50% Conversion
From concierge to platform — USD 0.7M → 16M.
Revenue · USD M
Updated FM · 50% one-time → meal plan conversion
EBITDA & Cumulative Cash · USD M
Operating profitability hits in FY3 · cash positive Q4
EBITDA
Cumulative Cash
| USD M | FY1 | FY2 | FY3 | FY4 | FY5 |
|---|---|---|---|---|---|
| Revenue | 0.69 | 1.76 | 4.63 | 8.98 | 16.05 |
| Gross Margin | 27% | 24% | 74% | 80% | 82% |
| EBITDA | (0.26) | (0.53) | 0.94 | 2.98 | 6.32 |
| Cumulative Cash | (0.53) | (1.12) | (0.39) | 2.05 | 7.32 |
Financials
24 / 31
Revised FM · Full Channel Stack
$16M FY5 is conservative. Real plan is $19M+.
Current FM models DTC + Clinic SaaS only. Signed non-SaaS B2B channels add a fourth revenue layer worth an incremental ~$4.6M USD by FY5, not yet reflected in the model shown on the prior slide.
FY5 Revenue Build · USD M
| Channel | FY5 USD M | GM | In FM |
|---|---|---|---|
| DTC · Nourish / Energize / Optimize | 3.8 | 44% | ✓ |
| DTC · Meal Plan Renewal | 1.2 | 37% | ✓ |
| B2B SaaS · Clinic Licensing | 9.5 | 85% | ✓ |
| Subtotal · Current FM | 14.5 | 61% | |
| B2B · VEO Fitness × Emaar | +1.4 | 28% | — |
| B2B · Meal Planet aggregator | +0.7 | 25% | — |
| B2B · Hotels (3–5 properties) | +1.3 | 30% | — |
| B2B · Corporate wellness (5–10) | +1.2 | 32% | — |
| TOTAL · Revised FY5 | 19.1 | 56% |
Revised FY5 Mix · USD M
Why the upside isn't hypothetical
VEO Fitness × Emaar finalizing · Meal Planet already live with 430 orders Q1 2026 · hotel inbounds via existing relationships · corporate channel active in GCC market for 10+ yrs. These are distribution channels, not prospects.
Implication for exit
7× revenue on revised FY5 → $134M base-case exit. At 11.1% equity, seed investor returns ~15× on $1M. Full 3-scenario framework on slide 29.
Revised FM · B2B Layer
25 / 31
Path to EBITDA Positivity
By Year 3 we trade 44% food margin for 85% software margin.
Operating unit economics positive from Month 8. EBITDA crosses zero in FY3. Cumulative cash flips in FY4.
EBITDA Trajectory · USD M · 5 Years
Conservative · backed by live traction
EBITDA
Cumulative Cash Flow
Cash needed
$1.12M
Peak funding gap (end of FY2). Covered by this $1M + retained margin.
Investment ask
$1M
SAFE · 11.1% equity at $8M pre-money cap.
Projected IRR
125%
From DCF · 13% cost of equity · 3% terminal growth.
Path to EBITDA
26 / 31
Year 1 · Bottom-Up Monthly Build
25 paying clients = profitability.
We're already at 8 paid + 21 funnel.
Conservative ramp at 20% MoM organic growth — roughly 2-3 new clients per month in Year 1. Low-volume / high-margin business model means profitability arrives at just 25 active clients (Month 8).
→
Month 1: 5 clientsStarting point post-funding · operational buildout. Margin -147%.
→
Month 8: 25 clientsFirst profitable month · meal plan retention 70% MoM compounds.
→
Month 12: 53 active clients · 17% marginYear 1 closes USD $0.69M revenue · ready to scale.
Active Clients vs Margin · Year 1 Monthly
FM bottom-up · 50% conversion · 70% retention
Active Clients
Operating Margin %
Today: 8 paying meal-plan subscribers + 21 clients in funnel (tested, undecided)
Not a projection. An arrival.
Profitability
27 / 31
Founders
Tech architect who exited to Emirates.
Operator who already runs the kitchen.
Mustafa Maghraby
CEO · Tech Architect · Capital
- Founded & exited DUBZ to Emirates Group — full M&A cycle
- 10+ years building tech & ops companies in the UAE
- Personally architected 80% of NEO-OS (Knowledge Base, Prioritization Engine, dashboards)
- Lived the problem first-hand · brings operator + investor relationships
Mariam Hourani
COO · Execution Moat
- Stanford-certified Nutritionist
- Founded RawKure — premium meal label · operating since 2019
- Brings ready kitchen infrastructure, supply chain & specialist network from Day 1
- Removes 12+ months of build time for any future competitor
Hiring next: Senior ML Engineer (NEO-OS) · Head of Clinic Partnerships (B2B) · Customer Success Lead
2 founders · 0 turnover · 100% aligned
Team
28 / 31
The Ask · Seed Round
Fund the final 20% of a platform 21 humans already paid for.
Raising
USD1M
SAFE · 24 months runway · profitability by Month 8 · 5 GCC clinic partners by Month 18 · KSA pre-launch by Month 20 · Series A on our terms.
InstrumentSAFE
Pre-money capUSD 8M
Post-moneyUSD 9M
Equity offered11.1%
Min ticketUSD 50K
Runway24 months
35%
Tech · NEO-OS Build-Out
Knowledge Base + Prioritization Engine + B2B clinic dashboard MVP. Final 20% of platform to production.
$350K
25%
Logistics · Kitchen + Supply Chain
Kitchen dashboard, specialist network, lab partnerships, bulk procurement to lock unit economics.
$250K
25%
Operations & Key Hires
Senior ML engineer · Head of Clinic Partnerships · Customer Success lead · marketing activation.
$250K
15%
KSA Pre-Launch + B2B Infrastructure
KSA regulatory & market entry prep · B2B fulfillment infra for VEO / Meal Planet / hotels · clinic onboarding tooling.
$150K
300+
Clients · M18
5
B2B Clinics
M8
Cash + EBITDA
$19M
FY5 Revenue
The Ask · $1M @ $8M cap
29 / 31
Returns & Exit · Three-Scenario Framework
$1M today, $95M–$191M exit in 5 years.
50% of FY5 revenue is B2B SaaS at 85% gross margin. That shifts the exit-multiple frame from food-business comps (4–6×) to platform-SaaS comps (7–10×). Three scenarios, benchmarked.
| Scenario | FY5 Rev · USD | Multiple | Exit Value | Seed Return | Multiple |
|---|---|---|---|---|---|
Conservative Current FM · 5× multiple |
$16M | 5× | $80M | $8.9M | 8.9× |
Base Case Revised FM · 7× multiple |
$19.1M | 7× | $134M | $14.9M | 14.9× |
Upside B2B over-execution · 10× multiple |
$25M | 10× | $191M | $21.2M | 21.2× |
Why 7× is Right
Function Health: 8–12× · InsideTracker: 6–8× · Thorne HealthTech (public): 5–7×. Base case sits on the conservative end of the comp set.
DCF Anchors
IRR 125% · 13% cost of equity · 3% terminal growth · NPV $18.4M · terminal value $30M · full model on request.
Seed Terms
$1M SAFE · $8M pre-money cap · 11.1% equity · 24-month runway · Series A from strength, not cash crunch.
Returns · 3 Scenarios
30 / 31
Stop Guessing.
Start Performing.
Your Biological Advantage · Built for the GCC
Contact
mustafa@neotrium.com · neotrium.com
Round
USD 1M · SAFE · 11.1% · Open Now
31 / 31